Page 6 - டோக்கியோ பல்கலைக்கழகம் ஆஃப் அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Anti-malarial drug shows promise in the battle against COVID-19 In the war that the world has been fighting against COVID-19, scientists have been scanning their arsenals of previously used drugs in hopes of finding any that can be used to treat the disease. One of the contenders under scrutiny, an anti-malarial drug called mefloquine shows great promise, according to a new breakthrough study by a team of Japanese scientists, perhaps giving us a better fighting chance. Early 2020 saw the world break into what has been described as a war-like situation : a pandemic, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), the likes of which majority of the living generations across most of the planet have not ever seen. This pandemic has downed economies and resulted in hundreds of thousands of deaths. At the dawn of 2021, vaccines have been deployed, but before populations can be sufficiently vaccinated, effective treatments remain the need of the hour

Kouji kuramochiMasako yamasakiKoichi watashiTomohiro tanakaEmily hendersonShin aokiHirofumi ohashiKaho shionoyaNational institute of infectious diseasesUniversity of tokyoKyoto universityKyushu universityScience groove incJapanese foundation for cancer researchTokyo university of scienceTokyo university